Skip to main content
Erschienen in: Journal of Thrombosis and Thrombolysis 3/2006

01.12.2006

A “two-step” educational approach for patients taking oral anticoagulants does not improve therapy control

verfasst von: Doris Barcellona, Paolo Contu, Francesco Marongiu

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 3/2006

Einloggen, um Zugang zu erhalten

Abstract

Background and objective

The educational aspect of oral anticoagulant treatment is considered a possible cause of variability in anticoagulation levels. The aim of this prospective study was to investigate whether the time spent in the therapeutic range (TSTR) by patients taking oral anticoagulants could be improved by two different, consecutive educational approaches on the crucial aspects of oral anticoagulant therapy.

Design and methods

Between May and June 2004, validated interviews were conducted with 240 patients (128 male and 112 female, mean age 50 ± 12 years) enrolled in the study. Three months later, the patients were randomly allocated to three groups. A course that focused on the questions in the interview was followed by the first group (n = 80); a brochure containing the correct answers to questions was given to the second (n = 81); nothing was provided for the third (n = 79).

Results

A significant difference was found in the TSTR between the quarters preceding and following the interview. Mean TSTR increase was 13%. Patients that were randomly selected to attend the educational course, read a brochure or do nothing showed similar TSTR percentages in the quarter following the interview. A good control of the anticoagulant therapy (TSTR >70%) was maintained, with no significant variation during the following three-quarters.

Interpretation and conclusions

A two-step educational approach for patients on long-term oral anticoagulation does not improve TSTR percentages in the short term.
Literatur
1.
Zurück zum Zitat Guida alla terapia con anticoagulanti orali (2006) Raccomandazioni della Federazione dei Centri per la diagnosi della trombosi e la Sorveglianza delle terapie Antitrombotiche (FCSA). Terzo accordo generale della Federazione. V Edizione Guida alla terapia con anticoagulanti orali (2006) Raccomandazioni della Federazione dei Centri per la diagnosi della trombosi e la Sorveglianza delle terapie Antitrombotiche (FCSA). Terzo accordo generale della Federazione. V Edizione
2.
Zurück zum Zitat Palareti G, Leali N, Coccheri S et al (1996) Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complication of Oral Anticoagulant Therapy. Lancet 348:423–428CrossRefPubMed Palareti G, Leali N, Coccheri S et al (1996) Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complication of Oral Anticoagulant Therapy. Lancet 348:423–428CrossRefPubMed
3.
Zurück zum Zitat Palareti G, Manotti C, D’Angelo A et al (1997) Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT study. Thromb Haemost 78:1438–1443PubMed Palareti G, Manotti C, D’Angelo A et al (1997) Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT study. Thromb Haemost 78:1438–1443PubMed
4.
5.
Zurück zum Zitat Wells PS, Holbrook AM, Crowther NR, Hirsh J (1994) Interaction of warfarin with drugs and food. Ann Intern Med 121:676–683PubMed Wells PS, Holbrook AM, Crowther NR, Hirsh J (1994) Interaction of warfarin with drugs and food. Ann Intern Med 121:676–683PubMed
6.
Zurück zum Zitat Marongiu F, Sorano GG, Conti M, Mameli G, Biondi G, Balestrieri A (1992) A known vitamin K intake and management of poorly controlled oral anticoagulant therapy. Lancet 340:545–546CrossRefPubMed Marongiu F, Sorano GG, Conti M, Mameli G, Biondi G, Balestrieri A (1992) A known vitamin K intake and management of poorly controlled oral anticoagulant therapy. Lancet 340:545–546CrossRefPubMed
7.
Zurück zum Zitat Booth SL, Charnley JM, Sadowski JA, Saltzman E, Bovill EG, Cushman M (1997) Dietary vitamin K1 and stability of oral anticoagulation: proposal of a diet with constant vitamin K1 content. Thromb Haemost 77:504–509PubMed Booth SL, Charnley JM, Sadowski JA, Saltzman E, Bovill EG, Cushman M (1997) Dietary vitamin K1 and stability of oral anticoagulation: proposal of a diet with constant vitamin K1 content. Thromb Haemost 77:504–509PubMed
8.
Zurück zum Zitat Manotti C, Quintavalla R, Pattacini C, Pini M (1994) Seasonal variation of oral anticoagulant effect. Thromb Haemost 71:802–803PubMed Manotti C, Quintavalla R, Pattacini C, Pini M (1994) Seasonal variation of oral anticoagulant effect. Thromb Haemost 71:802–803PubMed
9.
Zurück zum Zitat Kumar S, Haigh JR, Rhodes LE et al (1989) Poor compliance is a major factor in unstable outpatient control of anticoagulant therapy. Thromb Haemost 62:729–732PubMed Kumar S, Haigh JR, Rhodes LE et al (1989) Poor compliance is a major factor in unstable outpatient control of anticoagulant therapy. Thromb Haemost 62:729–732PubMed
10.
Zurück zum Zitat McCormick D, Gurwitz JH, Goldberg RJ et al (2001) Prevalence and quality of warfarin use in patients with atrial fibrillation in the long-term care setting. Arch Intern Med 161:2458–2463CrossRefPubMed McCormick D, Gurwitz JH, Goldberg RJ et al (2001) Prevalence and quality of warfarin use in patients with atrial fibrillation in the long-term care setting. Arch Intern Med 161:2458–2463CrossRefPubMed
11.
Zurück zum Zitat Cortellazzo S, Finazzi G, Viero P et al (1993) Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Thromb Haemost 69:316–320 Cortellazzo S, Finazzi G, Viero P et al (1993) Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Thromb Haemost 69:316–320
12.
Zurück zum Zitat Aithal GP, Day CP, Kesteven PJL, Daly AK (1999) Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet 353:717–719CrossRefPubMed Aithal GP, Day CP, Kesteven PJL, Daly AK (1999) Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet 353:717–719CrossRefPubMed
13.
Zurück zum Zitat Estrada CA, Hryniewicz MM, Higgs VB, Collins C, Byrd CJ (2000) Anticoagulant patient information material is written at high readability levels. Stroke 31:2966–2970PubMed Estrada CA, Hryniewicz MM, Higgs VB, Collins C, Byrd CJ (2000) Anticoagulant patient information material is written at high readability levels. Stroke 31:2966–2970PubMed
14.
Zurück zum Zitat Barcellona D, Contu P, Marongiu F (2002) Patient education and oral anticoagulant therapy. Haematologica 87:1081–1086PubMed Barcellona D, Contu P, Marongiu F (2002) Patient education and oral anticoagulant therapy. Haematologica 87:1081–1086PubMed
15.
Zurück zum Zitat Manotti C, Moia M, Palareti G, Pengo V, Ria L, Dettori AG (2001) Effect of computer-aided management on the quality of treatment in anticoagulated patients: a prospective, randomized, multicenter trial of APROAT (Automated Program for Oral Anticoagulant Treatment). Haematologica 86:1060–1070PubMed Manotti C, Moia M, Palareti G, Pengo V, Ria L, Dettori AG (2001) Effect of computer-aided management on the quality of treatment in anticoagulated patients: a prospective, randomized, multicenter trial of APROAT (Automated Program for Oral Anticoagulant Treatment). Haematologica 86:1060–1070PubMed
16.
Zurück zum Zitat Rosendaal FR, Cannegieter SC, van der Meer FJM, Briet E (1993) A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 69:236–237PubMed Rosendaal FR, Cannegieter SC, van der Meer FJM, Briet E (1993) A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 69:236–237PubMed
17.
Zurück zum Zitat Palareti G, Legnani C, Guazzaloca G, et al on behalf of the ad hoc study group of the Italian Federation of Anticoagulation Clinics (2005) Risks factors for highly unstable response to oral anticoagulation: a case–control study. Br J Haematol 129:72–78 Palareti G, Legnani C, Guazzaloca G, et al on behalf of the ad hoc study group of the Italian Federation of Anticoagulation Clinics (2005) Risks factors for highly unstable response to oral anticoagulation: a case–control study. Br J Haematol 129:72–78
18.
Zurück zum Zitat Laporte S, Quenet S, Buchmuller-Cordier A et al (2003) Compliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trial. Thromb Haemost 89:458–467PubMed Laporte S, Quenet S, Buchmuller-Cordier A et al (2003) Compliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trial. Thromb Haemost 89:458–467PubMed
19.
Zurück zum Zitat Barcellona D, Fenu L, Marongiu F (2003) Oral anticoagulant therapy: should doctors change the way they give patients explanations?Thromb Haemost 90:159–160 Barcellona D, Fenu L, Marongiu F (2003) Oral anticoagulant therapy: should doctors change the way they give patients explanations?Thromb Haemost 90:159–160
20.
Zurück zum Zitat Barcellona D, Contu P, Sorano GG, Pengo V, Marongiu F (2000) The management of oral anticoagulant therapy: the patient’s point of view. Thromb Haemost 83:49–53PubMed Barcellona D, Contu P, Sorano GG, Pengo V, Marongiu F (2000) The management of oral anticoagulant therapy: the patient’s point of view. Thromb Haemost 83:49–53PubMed
21.
Zurück zum Zitat Marongiu F, Barcellona D (2005) The future of anticoagulation clinics: a journey to thrombosis centres?Haematologica/THJ 90:298–301 Marongiu F, Barcellona D (2005) The future of anticoagulation clinics: a journey to thrombosis centres?Haematologica/THJ 90:298–301
Metadaten
Titel
A “two-step” educational approach for patients taking oral anticoagulants does not improve therapy control
verfasst von
Doris Barcellona
Paolo Contu
Francesco Marongiu
Publikationsdatum
01.12.2006
Erschienen in
Journal of Thrombosis and Thrombolysis / Ausgabe 3/2006
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-006-9027-2

Weitere Artikel der Ausgabe 3/2006

Journal of Thrombosis and Thrombolysis 3/2006 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.